Life ScienceCompany
CCD - Late Phase Division Ownership
Who owns CCD - Late Phase Division?
CCD - Late Phase Division is owned by Clinical Research Advantage. It was acquired on July 1, 2013.
CCD - Late Phase Division Business Overview
Where is CCD - Late Phase Division headquartered?
CCD - Late Phase Division is headquartered in United States.
What sector is CCD - Late Phase Division in?
CCD - Late Phase Division is a life science company.
Life Science M&A Summary in 2013
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.
Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.